Tag: ChAdOx1 nCoV-19 vaccine

AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC

pharmanewsdaily- August 15, 2020

AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up to 400 million doses of the AZD1222 ... Read More

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

ChAdOx1 nCoV-19 vaccine : Russia’s R-Pharm signs deal with AstraZeneca

pharmanewsdaily- July 17, 2020

Russian pharma company R-Pharm has reportedly signed an agreement with AstraZeneca for manufacturing the ChAdOx1 nCoV-19 vaccine being developed by the latter in collaboration with ... Read More

Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans

pharmanewsdaily- April 25, 2020

Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate's ... Read More